903 related articles for article (PubMed ID: 34089598)
1. High Prevalence of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (Anti-SARS-CoV-2) Antibodies After the First Wave of Coronavirus Disease 2019 (COVID-19) in Kinshasa, Democratic Republic of the Congo: Results of a Cross-sectional Household-Based Survey.
Nkuba AN; Makiala SM; Guichet E; Tshiminyi PM; Bazitama YM; Yambayamba MK; Kazenza BM; Kabeya TM; Matungulu EB; Baketana LK; Mitongo NM; Thaurignac G; Leendertz FH; Vanlerberghe V; Pelloquin R; Etard JF; Maman D; Mbala PK; Ayouba A; Peeters M; Muyembe JT; Delaporte E; Ahuka SM
Clin Infect Dis; 2022 Mar; 74(5):882-890. PubMed ID: 34089598
[TBL] [Abstract][Full Text] [Related]
2. High SARS-CoV-2 Seroprevalence after Second COVID-19 Wave (October 2020-April 2021), Democratic Republic of the Congo.
Munyeku-Bazitama Y; Folefack GT; Yambayamba MK; Tshiminyi PM; Kazenza BM; Otshudiema JO; Guinko NT; Umba MD; Mulumba A; Baketana LK; Mukadi PK; Smith C; Muyembe-Tamfum JJ; Ahuka-Mundeke S; Makiala-Mandanda S
Emerg Infect Dis; 2023 Jan; 29(1):89-97. PubMed ID: 36573545
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of COVID-19 infection in a densely populated district in the eastern Democratic Republic of Congo.
Irenge LM; Bulakali HM; Akonkwa AI; Ambroise J; Gala JL
Epidemiol Infect; 2023 Feb; 151():e24. PubMed ID: 36775822
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.
Murhekar MV; Bhatnagar T; Selvaraju S; Saravanakumar V; Thangaraj JWV; Shah N; Kumar MS; Rade K; Sabarinathan R; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chopra V; Das D; Deb AK; Devi KR; Dwivedi GR; Khan SMS; Kumar CPG; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Mohanty SS; Rangaraju C; Turuk A; Baradwaj DK; Chahal AS; Debnath F; Haq I; Kalliath A; Kanungo S; Kshatri JS; Lakshmi GGJN; Mitra A; Nirmala AR; Prasad GV; Qurieshi MA; Sahay S; Sangwan RK; Sekar K; Shukla VK; Singh PK; Singh P; Singh R; Varma DS; Viramgami A; Panda S; Reddy DCS; Bhargava B;
Lancet Glob Health; 2021 Mar; 9(3):e257-e266. PubMed ID: 33515512
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of anti-SARS-CoV-2 antibodies and risk of viral exposure among healthcare workers in the South Kivu province, eastern Democratic Republic of the Congo: a cross-sectional study.
Chasinga TB; Cikwanine JB; Kribi S; Yoyu JT; Hofmann N; Grossegesse M; Nitsche A; Tomczyk S; Vietor AC; Leendertz FH; Eckmanns T; Kusinza AB; Munguakonkwa E; Kalk A; Raha M; Kambale NS; Ayagirwe RB; Schubert G; Mukwege D
BMJ Open; 2024 Jan; 14(1):e072212. PubMed ID: 38176860
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 seroprevalence cohort survey among health care workers and their household members in Kinshasa, DR Congo, 2020-2022.
Madinga J; Mbala-Kingebeni P; Nkuba-Ndaye A; Baketana-Kinzonzi L; Matungulu-Biyala E; Mutombo-Lupola P; Seghers CA; Smekens T; Ariën KK; Van Damme W; Kalk A; Peeters M; Ahuka-Mundeke S; Muyembe-Tamfum JJ; Vanlerberghe V
J Health Popul Nutr; 2024 Jun; 43(1):74. PubMed ID: 38824595
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India.
Lone KS; Khan SMS; Qurieshi MA; Majid S; Pandit MI; Haq I; Ahmad J; Bhat AA; Bashir K; Bilquees S; Fazili AB; Hassan M; Jan Y; Kaul RR; Khan ZA; Mushtaq B; Nazir F; Qureshi UA; Raja MW; Rasool M; Asma A; Bhat AA; Chowdri IN; Ismail S; Jeelani A; Kawoosa MF; Khan MA; Khan MS; Kousar R; Lone AA; Nabi S; Qazi TB; Rather RH; Sabah I; Sumji IA
Front Public Health; 2022; 10():967447. PubMed ID: 36276377
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of anti-SARS-CoV-2 antibodies in people attending the two main Goma markets in the eastern Democratic Republic of the Congo.
Mitangala PN; Irenge LM; Musubao ET; Kahindo JBM; Ayonga PN; Kyembwa Safari I; Kubuya JB; Ntabe EN; Kabangwa Senga RK; Mutombo GN; Ambroise J; Gala JL
Epidemiol Infect; 2023 Sep; 151():e167. PubMed ID: 37724000
[TBL] [Abstract][Full Text] [Related]
9. [Seroprevalence of SARS-CoV-2 antibodies among travellers and workers screened at the Saint Luc Clinic in Bukavu, a city in eastern Democratic Republic of the Congo, from May to August 2020].
Katchunga PB; Murhula A; Akilimali P; Zaluka JC; Karhikalembu R; Makombo M; Bisimwa J; Mubalama E
Pan Afr Med J; 2021; 38():93. PubMed ID: 33889259
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
[TBL] [Abstract][Full Text] [Related]
11. High Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Prevalence After the Third Epidemic Wave (May-October 2021) in Matadi, Democratic Republic of the Congo.
Munyeku-Bazitama Y; Okitale-Talunda P; Mpingabo-Ilunga P; Yambayamba MK; Tshiminyi PM; Umba-Phuati A; Kimfuta J; Phukuta FA; Makindu G; Mufwaya-Nsene R; Asari R; Makimoto S; Baketana LK; Ahuka-Mundeke S; Isono M; Nsio-Mbeta J; Makiala-Mandanda S; Muyembe-Tamfum JJ
Open Forum Infect Dis; 2023 Jan; 10(1):ofad023. PubMed ID: 36726537
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 seroprevalence in vaccine-naïve participants from the Democratic Republic of Congo, Guinea, Liberia, and Mali.
Laverdure S; Kazadi D; Kone K; Callier V; Dabitao D; Dennis D; Haidara MC; Hunsberger S; Mbaya OT; Ridzon R; Sereti I; Shaw-Saliba K;
Int J Infect Dis; 2024 May; 142():106985. PubMed ID: 38417612
[TBL] [Abstract][Full Text] [Related]
13. High SARS-CoV-2 IgG/IGM seroprevalence in asymptomatic Congolese in Brazzaville, the Republic of Congo.
Batchi-Bouyou AL; Lobaloba Ingoba L; Ndounga M; Vouvoungui JC; Mfoutou Mapanguy CC; Boumpoutou KR; Ntoumi F
Int J Infect Dis; 2021 May; 106():3-7. PubMed ID: 33370565
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies in the Mozambican Population: A Cross-Sectional Serologic Study in 3 Cities, July-August 2020.
Arnaldo P; Mabunda N; Young PW; Tran T; Sitoe N; Chelene I; Nhanombe A; Ismael N; Júnior A; Cubula B; Inlamea OF; Gudo E; Jani IV
Clin Infect Dis; 2022 Oct; 75(Suppl 2):S285-S293. PubMed ID: 35748663
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibodies among unvaccinated children of Chandigarh, Northwest India, in a household-based paediatric serosurvey post-second wave of pandemic (June to July 2021).
Ghosh A; Goyal K; Singh R; Lakshmi PVM; Kaur R; Kumar V; Muralidharan J; Puri GD; Ram J; Singh MP
Public Health; 2023 Dec; 225():160-167. PubMed ID: 37931485
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of SARS-Cov-2 IgG antibodies in patients at a single center in Saudi Arabia.
Mahallawi WH; Alsarani MA; Aljohani RH; Alluhaibi AA; Alamri TH; Ibrahim NA; Mahallawi KH; Khabourd OF
Ann Saudi Med; 2022; 42(2):69-74. PubMed ID: 35380058
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of severe acute respiratory syndrome coronavirus 2 in Slovenia: results of two rounds of a nationwide population study on a probability-based sample, challenges and lessons learned.
Poljak M; Oštrbenk Valenčak A; Štrumbelj E; Maver Vodičar P; Vehovar V; Resman Rus K; Korva M; Knap N; Seme K; Petrovec M; Zupan B; Demšar J; Kurdija S; Avšič Županc T
Clin Microbiol Infect; 2021 Jul; 27(7):1039.e1-1039.e7. PubMed ID: 33838303
[TBL] [Abstract][Full Text] [Related]
18. Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys.
Angulo FJ; Finelli L; Swerdlow DL
JAMA Netw Open; 2021 Jan; 4(1):e2033706. PubMed ID: 33399860
[TBL] [Abstract][Full Text] [Related]
19. Estimated SARS-CoV-2 infection rate and fatality risk in Gauteng Province, South Africa: a population-based seroepidemiological survey.
Mutevedzi PC; Kawonga M; Kwatra G; Moultrie A; Baillie V; Mabena N; Mathibe MN; Rafuma MM; Maposa I; Abbott G; Hugo J; Ikalafeng B; Adelekan T; Lukhele M; Madhi SA
Int J Epidemiol; 2022 May; 51(2):404-417. PubMed ID: 34718591
[TBL] [Abstract][Full Text] [Related]
20. Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
Jones JM; Stone M; Sulaeman H; Fink RV; Dave H; Levy ME; Di Germanio C; Green V; Notari E; Saa P; Biggerstaff BJ; Strauss D; Kessler D; Vassallo R; Reik R; Rossmann S; Destree M; Nguyen KA; Sayers M; Lough C; Bougie DW; Ritter M; Latoni G; Weales B; Sime S; Gorlin J; Brown NE; Gould CV; Berney K; Benoit TJ; Miller MJ; Freeman D; Kartik D; Fry AM; Azziz-Baumgartner E; Hall AJ; MacNeil A; Gundlapalli AV; Basavaraju SV; Gerber SI; Patton ME; Custer B; Williamson P; Simmons G; Thornburg NJ; Kleinman S; Stramer SL; Opsomer J; Busch MP
JAMA; 2021 Oct; 326(14):1400-1409. PubMed ID: 34473201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
